Julie Morgan

Figma is also on our biggest movers list.

FIG is up 15% after reporting strong Q4 results and upbeat guidance.

And a couple of items on today's economic calendar at 8.30 a.m., jobless claims and at 10 a.m., leading indicators.

That's it for today's Wall Street Breakfast.

Thanks for listening.

To take full advantage of Seeking Alpha with coverage on significant stocks and ETFs, become a premium subscriber.

Check out seekingalpha.com slash subscriptions.

I'm your host, Julie Morgan.

Go out and make it a great day.

Welcome to Seeking Alpha's Wall Street Breakfast, where we cover the top news for investors every morning.

It's good to have you here on this Tuesday, February 17th.

I'm Julie Morgan.

Massimo is up 32% in pre-market action.

Danaher is nearing a roughly $10 billion deal to acquire the medical technology firm.

The Financial Times reported, citing people familiar with the matter, that a deal could be announced as early as today, provided it does not hit any last-minute snags.

The deal value represents a premium to its nearly $7 billion market cap at Friday's close.

Massimo manufactures pulse oximeters, which measures blood oxygen levels.

The company has challenged Apple over breaching its patents in a long-running intellectual property dispute over the Apple Watch.

The Massimo deal could be Danaher's biggest acquisition in more than half a decade.

Massimo's stock has declined by 27% over the past year.